In clinical testing, Shingrix demonstrated over 90% efficacy against herpes zoster in adults aged 50 years or older, with efficacy sustained during the 4-year follow-up period.
International Approvals …read more
In clinical testing, Shingrix demonstrated over 90% efficacy against herpes zoster in adults aged 50 years or older, with efficacy sustained during the 4-year follow-up period.
International Approvals …read more
Comments are closed.
Nice posts! 🙂
___
Sanny